CorMedix Inc.

CRMD

$8.65

Name : CorMedix Inc.

Sector : Healthcare

Industry: Biotechnology

Mark. Cap: $678,608,832.00

EPSttm : 2.17

CorMedix Inc.

$8.65

1.29%

$0.11

CRMD — Price & Float Short

—— Fair value ★ EPS beat ★ EPS miss —— Target Price

Float Short %

21.5

Margin Of Safety %

Put/Call OI Ratio

0.64

EPS Next Q Diff

-0.42

EPS Last/This Y

-1.74

EPS This/Next Y

-0.16

Price

8.65

Target Price

15.33

Analyst Recom

Performance Q

28.72

Upside

215.6%

Beta

1.46

Ticker: CRMD

20 items of 1

Date	Symbol	Latest	P/C OI	P/C Vol	Total OI
2026-05-11	CRMD	7.65	0.70	0.27	68479
2026-05-12	CRMD	7.51	0.70	0.21	68650
2026-05-13	CRMD	7.49	0.69	0.26	69472
2026-05-14	CRMD	7.93	0.68	0.07	70146
2026-05-15	CRMD	7.55	0.67	0.69	71188
2026-05-18	CRMD	7.92	0.75	0.13	48085
2026-05-19	CRMD	7.83	0.73	0.18	49935
2026-05-20	CRMD	7.93	0.72	3.15	50442
2026-05-21	CRMD	8.05	0.72	0.35	50815
2026-05-22	CRMD	7.99	0.72	0.95	50795
2026-05-26	CRMD	8.28	0.71	0.20	50896
2026-05-27	CRMD	8.46	0.69	0.03	51845
2026-05-28	CRMD	8.43	0.66	0.05	53383
2026-05-29	CRMD	8.43	0.66	0.12	53601
2026-06-02	CRMD	8.16	0.66	0.15	54300
2026-06-03	CRMD	8.23	0.65	0.73	54548
2026-06-04	CRMD	8.54	0.66	0.13	54699
2026-06-05	CRMD	8.35	0.65	0.81	55083
2026-06-08	CRMD	8.52	0.64	0.20	55005
2026-06-09	CRMD	8.64	0.64	0.51	55161
Date	Symbol	Latest	P/C OI	P/C Vol	Total OI

20 items 1 of 1

21 items of 1

Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year
2026-05-11	CRMD	7.64	10.0	-	0.79
2026-05-12	CRMD	7.51	10.0	-	0.79
2026-05-13	CRMD	7.49	10.0	-	0.79
2026-05-14	CRMD	7.93	10.0	-	0.79
2026-05-15	CRMD	7.56	10.0	-	0.79
2026-05-18	CRMD	7.91	10.0	-	0.79
2026-05-19	CRMD	7.82	10.0	-	0.79
2026-05-20	CRMD	7.94	10.0	-	0.79
2026-05-21	CRMD	8.05	10.0	-	0.79
2026-05-22	CRMD	7.99	-5.4	-	0.97
2026-05-26	CRMD	8.27	-5.4	-	0.97
2026-05-27	CRMD	8.47	-5.4	-	0.97
2026-05-28	CRMD	8.43	-5.4	-	0.97
2026-05-29	CRMD	8.43	-5.4	-	0.97
2026-06-01	CRMD	8.44	-3.6	-	0.51
2026-06-02	CRMD	8.16	-3.6	-	0.51
2026-06-03	CRMD	8.23	-3.6	-	0.51
2026-06-04	CRMD	8.55	-3.6	-	0.51
2026-06-05	CRMD	8.36	-3.6	-	0.51
2026-06-08	CRMD	8.52	-3.6	-	0.51
2026-06-09	CRMD	8.65	-3.6	-	0.51
Date	Ticker	Price	Current Quarter Growth Estimate	EBIT Estimation	Average EPS Estimate Current Year

21 items 1 of 1

20 items of 1

Date	Ticker	Insider Transactions	Institutional Transactions	Float Short
2026-05-11	CRMD	-2.88	-11.01	22.32
2026-05-12	CRMD	-2.88	-11.01	23.03
2026-05-13	CRMD	-2.88	-11.01	23.03
2026-05-14	CRMD	-2.88	-11.01	23.03
2026-05-15	CRMD	-2.88	-11.01	23.03
2026-05-18	CRMD	-2.88	-8.81	23.04
2026-05-19	CRMD	-2.50	-8.81	23.04
2026-05-20	CRMD	-2.50	-8.81	23.04
2026-05-21	CRMD	-2.50	-8.81	22.69
2026-05-22	CRMD	-2.90	-8.81	22.69
2026-05-26	CRMD	-2.90	-1.34	22.69
2026-05-27	CRMD	-2.54	-1.34	22.69
2026-05-28	CRMD	-2.54	-1.34	21.73
2026-05-29	CRMD	-2.54	-1.34	21.73
2026-06-02	CRMD	-2.54	-2.20	20.22
2026-06-03	CRMD	-10.33	-2.20	20.22
2026-06-04	CRMD	-10.33	-2.20	20.22
2026-06-05	CRMD	-7.87	-2.20	21.50
2026-06-08	CRMD	-2.13	-2.18	21.50
2026-06-09	CRMD	-2.13	-2.18	21.50
Date	Ticker	Insider Transactions	Institutional Transactions	Float Short

20 items 1 of 1

Last Quarter Act. EPS

0.43

Avg. EPS Est. Current Quarter

0.27

Avg. EPS Est. Next Quarter

0.01

Insider Transactions

-2.13

Institutional Transactions

-2.18

Beta

1.46

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

10.96

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

50.4

Max Drawdown 5-Year %

-66.9

Target Price

15.33

P/E

4.12

Forward P/E

66.54

PEG

P/S

1.7

P/B

1.55

P/Free Cash Flow

3.49

EPS

2.1

Average EPS Est. Cur. Y

0.51

EPS Next Y. (Est.)

0.35

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

45.25

Relative Volume

1.11

Return on Equity vs Sector %

13.7

Return on Equity vs Industry %

29.8

EPS 1 7Days Diff

-0.1

EPS 1 30Days Diff

-0.15

EBIT Estimation

◆ CRMD Healthcare

$8.65

📉

Swing / Pullback

Buy the dip on strong trends

WEAK

Trend

14/20

Pullback

8/25

Volume

4/15

Valuation

18/20

TP/AR

2/10

Options

7/10

RSI

63.4

Range 1M

78.2%

Sup Dist

2.8%

🚀

Momentum Growth

Ride accelerating trends

N/A

WEAK

Momentum

9/25

Growth

14/30

Estimates

4/20

Inst/Vol

5/15

Options

5/10

EPS Yr

-75.2%

EPS NY

-74.3%

52W%

22%

💎

Long-Term Value

Quality companies, undervalued

WEAK

🔴 SELL -0.2% upside

Quality

25/30

Valuation

6/30

Growth

8/25

Stability

5/10

LT Trend

3/5

Upside

-0.2%

Quality

MoS

27%

CorMedix Inc.

Sector: Healthcare

Industry: Biotechnology

Employees: 191

CorMedix Inc., a biopharmaceutical company, focuses on developing and commercializing therapeutic products for life-threatening diseases and conditions in the United States. Its lead product candidate is DefenCath, an antimicrobial catheter lock solution to reduce the incidence of catheter-related bloodstream infections in adult patients with kidney failure. CorMedix Inc. was formerly known as Picton Holding Company, Inc. and changed its name to CorMedix, Inc. in January 2007. The company was incorporated in 2006 and is based in Parsippany, New Jersey.

CRMD

Latest News

—

Caricamento notizie per CRMD…

stock quote shares CRMD – CorMedix Inc. Stock Price stock today

news today CRMD – CorMedix Inc. stock forecast ,stock prediction 2023 2024 2025

marketwatch CRMD – CorMedix Inc. yahoo finance google finance

stock history CRMD – CorMedix Inc. invest stock market

stock prices CRMD premarket after hours

ticker CRMD fair value insiders trading

Float Short %

Margin Of Safety %

Put/Call OI Ratio

EPS Next Q Diff

EPS Last/This Y

EPS This/Next Y

Price

Target Price

Analyst Recom

Performance Q

Upside

Beta

Ticker: CRMD

Last Quarter Act. EPS​

Avg. EPS Est. Current Quarter

Avg. EPS Est. Next Quarter

Insider Transactions

Institutional Transactions

Beta

Average Sales Estimate Current Quarter

Average Sales Estimate Next Quarter

Fair Value

Quality Score

Growth Score

Sentiment Score

Actual DrawDown %

Max Drawdown 5-Year %

Target Price

P/E

Forward P/E

PEG

P/S

P/B

P/Free Cash Flow

EPS

Average EPS Est. Cur. Y​

EPS Next Y. (Est.)

Target Price Estimates Raised

Target Price Estimates Lowered

Profit Margin

Relative Volume

Return on Equity vs Sector %

Return on Equity vs Industry %

EPS 1 7Days Diff

EPS 1 30Days Diff

EBIT Estimation

Latest News

Last Quarter Act. EPS

Average EPS Est. Cur. Y